4
Changes in Ownership
Taysha Gene Therapies, Inc. Filed Acc 0001209191-20-052462
Director acquired 1,091,101 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Nolan Sean P. Director | 2020-09-28 | Conversion | +1,089,500 | 1,089,500 | I | ||
| Nolan Sean P. Director | 2020-09-28 | Conversion | +1,601 | 1,091,101 | I | ||
| Derivatives | |||||||
| Nolan Sean P. Director | 2020-09-28 | Conversion · Series A Preferred Stock | −1,000,000 | 0 | I | ||
| Nolan Sean P. Director | 2020-09-28 | Conversion · Series B Preferred Stock | −1,470 | 0 | I | ||
Loading xslF345X03/doc4.xml…